H-Index
70
Scimago Lab
powered by Scopus
Clarivate
Analytics
Formerly the IP & Science
business of Thomson Reuters

Logo




eISSN: 1643-3750

Associations of Prostate-Specific Antigen, Prostate Carcinoma Tissue Gleason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate Carcinoma

Yehui Chen, Yun Lin, Pin Nie, Wen Jiang, Yanqing Liu, Runqiang Yuan, Miaoyuan Li, Shijia Zhao, Huaxin Lin, Penghui Li, Jinxiang Zhang, Zhiwen Hu, Jin Xu, Xusheng Zhu

(Department of Urology, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China (mainland))

Med Sci Monit 2017; 23:1768-1774

DOI: 10.12659/MSM.900977

Published: 2017-04-12


BACKGROUND: Prostate carcinoma (PCa) is often not diagnosed until advanced disease with bone metastasis. Predictive factors for bone metastasis are required to improve patient outcomes. The study aimed to analyze the factors associated with bone metastases in newly diagnosed patients with PCa.
MATERIAL AND METHODS: This was a retrospective study of 80 patients newly diagnosed with PCa by pathological examination between January 2012 and December 2014. Bone metastases were diagnosed by positron emission computed tomography. Clinical data, serological laboratory results, and pathological examination results were collected.
RESULTS: Among the 80 patients, 45 (56%) had bone metastases. Age, serum alkaline phosphatase, prostate-specific antigen (PSA), erythrocyte sedimentation rate, PCa tissue Gleason score, androgen receptor (AR) expression, and Ki-67 expression were higher in patients with bone metastasis compared with those without (all P<0.05). Multivariate logistic regression showed that PSA (OR: 1.005; 95%CI: 1.001–1.010; P=0.016), Gleason score (OR: 4.095; 95%CI: 1.592–10.529; P=0.003), and AR expression (OR: 14.023; 95%CI: 3.531–55.6981; P=0.005) were independently associated with bone metastases. Cut-off values for PSA, Gleason score, and AR expression were 67.1 ng/ml (sensitivity: 55.6%; specificity: 97.1%), 7.5 (sensitivity: 75.6%; specificity: 82.9%), and 2.5 (sensitivity: 84.0%; specificity: 91.4%), respectively.
CONCLUSIONS: PSA, Gleason score, and AR expression in PCa tissues were independently associated with PCa bone metastases. These results could help identifying patients with PCa at high risk of bone metastases.

Keywords: Neoplasm Grading, Prostate-Specific Antigen, Prostatic Neoplasms, Receptors, Androgen



Back